Signals From [Space]

Signals From [Space]

Home
Podcast
🟩 VBC Directory
🟩 Data Room
Slack
Careers
About
John Erbey on Targeting the Kidney’s Collecting System to Improve Fluid Removal & Sustain Function: Signals KOLs
Part 2: Roivios CEO John Erbey explains how shifting focus from arterial blood flow to the kidney’s collecting system may enhance fluid removal, support…
 • 
Tim Fitzpatrick
10:41
John Erbey on the $650 billion kidney crisis and the problem no one seems to talking about: Signals KOLs
Part 1: Roivios CEO John Erbey shares how his team came together and why tackling CKD before it reaches end-stage kidney failure is critical to saving…
 • 
Tim Fitzpatrick
3
9:39
Signals Recap: Mass Layoffs at HHS & VA; NYT Investigates Transplant Chaos; FDA Fast-Tracks Kidney Cancer Drug & More…
Your biweekly collection of news, research, funding & community voices shaping the future of global kidney health
 • 
Tim Fitzpatrick

February 2025

Signals Brief: DaVita Earnings in Q4 2024
Earnings, Cost Pressures, and the Road Ahead: IKC Expansion, Helene’s Impact, Year-over-year Comps, and the Oral Drug Reimbursement Shift
 • 
Tim Fitzpatrick
Signals Recap: Humana-Monogram, FDA Approves Xeno Trials, Travere Targets FSGS, National Donor Day, & More...
Your collection of news, research, funding & community voices shaping the future of global kidney health
 • 
Tim Fitzpatrick
2
KCC in Numbers: What We Know, What We Don't, and What Comes Next
PY23 Preview: Making Sense of KCC Data—Spending, Quality, and Key Outcomes
 • 
Tim Fitzpatrick
Signals Recap: Ozempic's Latest Approval, EKDA on Reddit, Lilly Stops Relaxin, Beta Bionics IPO, NKF Turns 75, & More...
A collection of news, research, funding & community voices shaping the future of global kidney health
 • 
Tim Fitzpatrick
3

January 2025

Welcome to the Kidneyverse
Start here. This piece explores the vast landscape of unmet needs driving the ideas, innovations, and investments that will shape the future of global…
 • 
Tim Fitzpatrick
Update: We should probably talk about barriers to home dialysis
An update on the latest USRDS data, trends, and key challenges in home dialysis adoption, including payer impacts, infrastructure needs, and patient…
 • 
Tim Fitzpatrick
2
9:55
Signals Recap: Azar on VBC, Carilion-UVa, TransMedics, JPM Takeaways, Ozempic, Vafseo, & More...
A collection of news, research, funding & community voices shaping the future of global kidney health
 • 
Tim Fitzpatrick
1
The State & Future of Nutrition in Kidney Health: Expert Q&A
How 5 experts think about progress, pitfalls, and potential in this space
 • 
Tim Fitzpatrick
, 
Rory Pace
, 
Bethany Keith
, 
Karla Rippchen
, and 
Cory Zenner
21:54
Osman Khawar (Diality) on Moda-Flx and the need for more flexible dialysis treatment options: Signals KOLs
Diality CEO Dr. Osman Khawar sits down with Dr. Alice Wei for a show-and-tell with their recently FDA approved Moda-flx Hemodialysis System
 • 
Tim Fitzpatrick
 and 
Alice Wei, MD
6:16
© 2025 Tim Fitzpatrick
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture